Methods and systems for enhancing fluid flow trough an obstructed vascular site
Abstract
(57) The system and kit for the strengthening method of the fluid flow of the pulse pipe part which carried out the summary pulse pipe (blood vessel) blockade, and the use which enforces this method are offered. The flash of the pulse pipe part is carried out in implementation of the present invention, using simultaneously the first dissolution fluid (for example, organic matter dissolution fluid and/or inorganic substance dissolution fluid) and the second dissolution fluid diluting fluid. Here, flashing is performed in the style that only the surface of a pulse pipe blockade contacts non-diluting dissolution fluid. It is a fluid; (2) surface-active-agent fluid and phosphoric acid buffering physiological saline; (3) acidic solution, phosphoric acid buffering physiological saline, etc. Which contain: (1) oxidizer fluid and the neutralizer which can be oxidized in which the following is mentioned as a pair of example of dissolution fluid / dissolution fluid diluting fluid. Flashing is performed in this style during sufficient period for the fluid flow of the pulse pipe part which should be strengthened (increase or establishment). In the disposal of the pulse pipe disease characterized by pulse pipe blockade, the method, system, and kit of the present invention find out a use.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
64 members in 8 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 52857600 | United States of America | A | |
| 77446901 | United States of America | A | |
| 0107155 | United States of America | W |
Members64
| Document | Office | Kind | |
|---|---|---|---|
| CA2337113A1 | Canada | A1 | |
| WO0003651A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU5101699A | Australia | A | |
| CA2382351A1 | Canada | A1 | |
| WO0115767A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU6936600A | Australia | A | |
| EP1100392A1 | European Patent Office (EPO) | A1 | |
| US6290689B1 | United States of America | B1 | |
| CA2403533A1 | Canada | A1 | |
| WO0170320A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU4546801A | Australia | A | |
| US2001039411A1 | United States of America | A1 | |
| US2001041865A1 | United States of America | A1 | |
| US2002044907A1 | United States of America | A1 | |
| US6379345B1 | United States of America | B1 | |
| US6387071B1 | United States of America | B1 | |
| US6394096B1 | United States of America | B1 | |
| EP1229959A1 | European Patent Office (EPO) | A1 | |
| US6488671B1 | United States of America | B1 | |
| EP1229959A4 | European Patent Office (EPO) | A4 | |
| US2003018297A1 | United States of America | A1 | |
| US6527979B2 | United States of America | B2 | |
| US6533767B2 | United States of America | B2 | |
| EP1294422A1 | European Patent Office (EPO) | A1 | |
| US6562020B1 | United States of America | B1 | |
| US2003104073A1 | United States of America | A1 | |
| JP2003522560A | Japan | A | |
| JP2003527225A | Japan | A | |
| US6622732B2 | United States of America | B2 | |
| US2003199820A1 | United States of America | A1 | |
| US2004077992A1 | United States of America | A1 | |
| US6730063B2 | United States of America | B2 | |
| EP1100392A4 | European Patent Office (EPO) | A4 | |
| US2005059955A1 | United States of America | A1 | |
| US2006161099A1 | United States of America | A1 | |
| US2006161103A1 | United States of America | A1 | |
| US7141045B2 | United States of America | B2 | |
| EP1294422A4 | European Patent Office (EPO) | A4 | |
| US2007173784A1 | United States of America | A1 | |
| EP1100392B1 | European Patent Office (EPO) | B1 | |
| AT423519T | Austria | T | |
| ATE423519T1 | Austria | T1 | |
| DE69940471D1 | Germany | D1 | |
| EP2055249A1 | European Patent Office (EPO) | A1 | |
| EP1229959B1 | European Patent Office (EPO) | B1 | |
| AT431172T | Austria | T | |
| ATE431172T1 | Austria | T1 | |
| CA2337113C | Canada | C | |
| DE60042213D1 | Germany | D1 | |
| EP2075031A1 | European Patent Office (EPO) | A1 | |
| EP1294422B1 | European Patent Office (EPO) | B1 | |
| AT458525TThis record | Austria | T | |
| ATE458525T1 | Austria | T1 | |
| DE60141400D1 | Germany | D1 | |
| EP2241271A1 | European Patent Office (EPO) | A1 | |
| EP2241271B1 | European Patent Office (EPO) | B1 | |
| AT527943T | Austria | T | |
| ATE527943T1 | Austria | T1 | |
| JP4804693B2 | Japan | B2 | |
| EP2055249B1 | European Patent Office (EPO) | B1 | |
| AT535199T | Austria | T | |
| ATE535199T1 | Austria | T1 | |
| US8500683B2 | United States of America | B2 | |
| CA2403533C | Canada | C |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER | RER |
Numbers
- Application
- 1918386
Titles2
- German
- MEDIZINISCHES SYSTEM ZUR REDUZIERUNG VASKULÄRER OBSTRUKTIONEN
- English
- MEDICAL SYSTEM FOR REDUCING VASCULAR OBSTRUCTIONS
Classification
- CPC, 16
- A61B5/14539
- A61B17/22
- A61B2017/22084
- A61K31/00
- A61K33/00
- A61K45/06
- A61M25/007
- A61M25/10
- A61M25/1011
- A61M2025/0004
- A61M2025/0034
- A61M2025/0175
- A61M2025/1015
- A61M2025/105
- A61M2025/1052
- A61M2025/109
- IPC, 7
- A61B17 00
- A61B17 22
- A61F2 958
- A61K31 00
- A61K33 00
- A61K45 06
- A61M25 00